Rachel Haurwitz

Rachel Haurwitz

Founder at CARIBOU BIOSCIENCES, INC.

Net worth: 18 M $ as of 2024-03-30

38 year
Health Technology
Commercial Services
Consumer Services

Profile

Rachel E.
Haurwitz
is the founder and has held multiple positions throughout her career.
She founded Caribou Biosciences, Inc. in 2011, where she currently serves as the President, Chief Executive Officer & Director.
In 2014, she also founded Intellia Therapeutics, Inc. and served as a Director until 2016.
In addition to her founding positions, Dr. Haurwitz currently holds several jobs.
Since 2020, she has been a Director at the Biotechnology Innovation Organization.
Since 2019, she has also been a Director at BIOCOM.
Furthermore, in 2021, she became an Independent Director at Seer, Inc. (California).
Dr. Haurwitz's education includes a doctorate from the University of California, Berkeley, and an undergraduate degree from Harvard College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-19 3,508,095 ( 3.88% ) 18 M $ 2024-03-30
2023-06-13 29,437 ( 0.05% ) 55 930 $ 2024-03-30

Rachel Haurwitz active positions

CompaniesPositionStart
CARIBOU BIOSCIENCES, INC. Founder 2011-10-27
SEER, INC. Director/Board Member 2021-11-07
Director/Board Member 2019-02-25
Director/Board Member 2020-01-31
All active positions of Rachel Haurwitz

Former positions of Rachel Haurwitz

Training of Rachel Haurwitz

University of California, Berkeley Doctorate Degree
Harvard College Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rachel Haurwitz's experience

Connections

100 +

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
CARIBOU BIOSCIENCES, INC.

Health Technology

INTELLIA THERAPEUTICS, INC.

Health Technology

SEER, INC.

Health Technology

Private companies2

Commercial Services

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Rachel Haurwitz